Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
177
result was found. Results that relate to
Drug
Prediction of aripiprazole blood concentration by GA-BP artificial neural network
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):59-66.
1098 times
484 times
Ze-Ping YANG
Ting ZHAO
Ting-Ting WANG
Jie FENG
Hui-Lan ZHANG
Li SUN
Hong-Jian LI
Lu-Hai YU
Genetic algorithm back propagation
Artificial neural network
Aripiprazole
Dehydroaripiprazole
Prediction of blood drug concentration
Details
Monitoring of trough concentration of mycophenolic acid in plasma of patients with systemic lupus erthematosus by LC-MS/MS
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):67-73.
1295 times
402 times
Xi-Ping LI
Heng-Yi YU
Dong XIANG
Dong LIU
Xue-Peng GONG
Mycophenolic acid
LC-MS/MS
Therapeutic drug monitoring
Systemic lupus erythematosus
Details
Research and pharmaceutical services by clinical pharmacists on antibiotic-related drug interaction in ICU
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):125-1131.
1112 times
332 times
Hai-Tao WANG
Kang-Huai ZHANG
Jiao XIE
Na WANG
Qian-Ting YANG
Yan CAI
You-Jia LI
Li ZHANG
Yan WANG
Antimicrobial agents
Potential drug-antimicrobial agent interactions
Intensive care unit
Pharmaceutical intervention
Details
A case of acute renal injury caused by improper administration of valaciclovir tablets
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):136-139.
1301 times
552 times
Meng-Meng WANG
Fei HAO
Yan-Ni ZHANG
Valaciclovir
Acute kidney injury
Irrational drug use
Adverse drug reaction
Details
A case analysis of pancreatitis caused by dulaglutide
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):140-144.
1462 times
398 times
Di HUAN
Jing MA
Zi-Jing WU
Jia-Hui LI
Rui WANG
Wen-Xiang LI
Dulaglutide
Pancreatitis
Adverse drug reactions
Glucagon like peptide-1 receptor agonist
Details
Evaluation of the rationality of prophylactic antibiotics in perioperative period for cesarean section before and after clinical pharmacists intervention based on entropy weight TOPSIS method
Published on
Journal of Mathematical Medicine
2023,36(11):818-823.
1324 times
495 times
Nan LI
Wei LIU
Yan-Zhong ZHANG
Antibacterial drugs
Cesarean section
Perioperative period
TOPSIS
Clinical pharmacist
Rational drug use
Details
Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1201-1208.
1654 times
530 times
Xiao-Lan LIAO
Jia-Qi GE
Hai-Bin ZHU
Ting-Ting WU
Chun-Xia REN
Zi-Cheng YU
Vascular endothelial growth factor receptor-tyrosine kinase inhibitors
Hypertension
Adverse drug events
Pharmacovigilance
FAERS database
Details
Poly ADP-ribose polymerase inhibitor-induced thrombocytopenia: recent advances in pathogenesis and treatments
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1209-1216.
1377 times
492 times
Ying-Chen ZHUO
Su-Ya ZHANG
Peng-Fei SONG
Wei-Yi FENG
Poly ADP-ribose polymerase inhibitor
Thrombocytopenia
Ovarian cancer
Adverse drug reaction
Details
Practice and reflection of pharmacovigilance system construction
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1217-1224.
1711 times
635 times
Na WANG
Kang-Huai ZHANG
Pharmacovigilance
Drug
use safety
Risk prevention and control
Adverse drug reaction
Medication error
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1225-1230.
1726 times
588 times
Ting-Ting ZHENG
Jin LI
Lu MAO
Ning CHEN
Wei ZHANG
Jian-Cun ZHEN
Rational drug use
Abnormal early warning
Dynamic monitoring
Clinical pharmacist
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1238-1242.
1513 times
545 times
Hao-Chun TANG
Jun MENG
Zheng-Zheng XIA
Ling-Zhi REN
Non-small cell lung cancer
Pyrotinib
Adverse drug reaction
Safety
Off-indication
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1243-1249.
1294 times
452 times
An-Hua WEI
Wen-Jing LI
Yan HUANG
Dabigatran etexilate
Potential drug-drug interactions
Safety
Retrospective study
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1285-1295.
1302 times
984 times
Chao YE
Xin LI
Li-Hua LIU
Xin HE
Shen-Jue CHEN
Juan WANG
Tacrolimus
Acute pancreatitis
Case report
Adverse drug reactions
Literature analysis
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):19-27.
1174 times
917 times
ZHANG Yinan
WU Tingxi
ZHAO Zhigang
Drug
benefit-risk communication
Safety communication
Drug
safety information
Pharmacovigilance
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1311-1315.
1461 times
473 times
Jin-Jin ZOU
Ji-Liang ZHANG
Ni LI
Ding-Yi LIU
Pembrolizumab
Lung squamous cell carcinoma
Severe immune-related ulcerative colitis
Adverse drug reactions
Details
上一页
1
2
3
4
5
6
7
8
9
10
11
12
下一页